论文部分内容阅读
由北京市医药总公司主持召开的药物释放度研究成果鉴定会,于今年2月25日至26日在北京举行。鉴定会听取了北京释放度协作组关于药物生物利用度和释放度研究的总结、关于生物利用度和释放度在处方、工艺及剂型设计和改进的应用的报告和仪器协作单位——江苏武进精密仪器厂关于80-1型药物释放度测定仪试制工作的汇报。会议还听取了北京制药厂关于阿司匹林缓冲片(心湿林片)研制的总结报告。与会代表经过讨论,对该项研究成果给予肯定,并一致认为,北京释放度研究协作组的研究,在数理统计的数据处理上,提供了新的方法,为进一步开展这项研究奠定了基础。对阿司匹林剂型的生物利用度和释放度进行的一系列研究,为国内填补了空白。801型药物释放度测定仪通过试用和改进,已达到应
The appraisal meeting of drug release research results, chaired by Beijing Pharmaceutical Corporation, was held in Beijing from February 25 to February 26 this year. Appraisal will listen to the Beijing release of collaborative group on drug bioavailability and release of the summary of the study on the bioavailability and release of prescriptions, process and formulation design and application of improved reporting and instrumentation units - Jiangsu Wujin Precision Instrument factory on the 80-1 type of drug release tester trial work report. The meeting also heard the summary report of the Beijing Pharmaceutical Factory on the development of aspirin buffer tablets. After discussion, the delegates affirmed the research results and agreed that the research on the collaborative group of Beijing Release Research Institute provided a new method for the data processing of mathematical statistics, which laid the foundation for further carrying out the study. A series of studies on the bioavailability and release of aspirin dosage forms have filled the gap in China. 801 type drug release tester through trial and improvement, has been achieved